Entera Bio (ENTX) Short Interest Ratio & Short Volume $2.24 +0.01 (+0.45%) As of 10:12 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio Short Interest DataEntera Bio (ENTX) has a short interest of 73,100 shares, representing 0.23% of the float (the number of shares available for trading by the public). This marks a -2.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 79,330 shares to cover all short positions.Current Short Interest73,100 sharesPrevious Short Interest74,800 sharesChange Vs. Previous Month-2.27%Dollar Volume Sold Short$132,311.00Short Interest Ratio1.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares45,421,000 sharesShort Percent of Float0.23%Today's Trading Volume5,784 sharesAverage Trading Volume79,330 sharesToday's Volume Vs. Average7% Short Selling Entera Bio? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202573,100 shares $132,311.00 -2.3%0.2%1.3 $1.81 3/31/202574,800 shares $127,160.00 -13.1%0.2%1.1 $1.70 3/15/202586,100 shares $161,868.00 -13.7%0.3%0.8 $1.88 2/28/202599,800 shares $184,630.00 -4.5%0.3%0.8 $1.85 2/15/2025104,500 shares $253,935.00 +59.5%0.3%0.9 $2.43 1/31/202565,500 shares $143,445.00 -31.6%N/A0.5 $2.19 1/15/202595,800 shares $218,424.00 +102.5%N/A0.7 $2.28 12/31/202447,300 shares $100,276.00 -23.1%N/A0.4 $2.12 12/15/202461,500 shares $132,840.00 -2.4%N/A0.9 $2.16 11/30/202463,000 shares $103,320.00 +19.8%N/A0.9 $1.64 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 11/15/202452,600 shares $90,998.00 +19.0%N/A0.8 $1.73 10/31/202444,200 shares $80,002.00 +9.4%N/A1.4 $1.81 10/15/202440,400 shares $73,124.00 -14.4%N/A1.1 $1.81 9/30/202447,200 shares $89,680.00 +38.4%N/A1.2 $1.90 9/15/202434,100 shares $67,859.00 +27.7%N/A0.7 $1.99 8/31/202426,700 shares $44,589.00 -4.0%N/A0.5 $1.67 8/15/202427,800 shares $44,480.00 +11.7%N/A0.5 $1.60 7/31/202424,900 shares $40,089.00 -51.0%N/A0.3 $1.61 7/15/202450,800 shares $94,996.00 -29.4%N/A0.5 $1.87 6/30/202471,900 shares $132,296.00 -7.2%N/A0.4 $1.84 6/15/202477,500 shares $160,425.00 -15.2%N/A0.4 $2.07 5/31/202491,400 shares $205,650.00 -28.0%N/A0.4 $2.25 5/15/2024127,000 shares $332,740.00 +260.8%N/A0.5 $2.62 4/30/202435,200 shares $68,992.00 -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226,548.00 +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147,294.00 +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11,097.00 +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1,787.50 -95.0%N/A0 $1.38 2/15/202426,100 shares $27,405.00 +715.6%N/A0.3 $1.05 1/31/20243,200 shares $2,655.36 -80.5%N/A0 $0.83 1/15/202416,400 shares $17,876.00 -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37,680.00 +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39,055.50 -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47,919.28 -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50,492.10 +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37,302.08 +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36,500.00 -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43,137.50 +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34,455.50 +89.1%0.2%1.3 $0.69 8/31/202326,600 shares $17,822.00 +24.9%0.1%0.8 $0.67Trump to solve American wealth loss? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 8/15/202321,300 shares $12,782.13 -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29,388.00 +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8,560.76 -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19,145.18 +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4,871.43 -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26,010.40 -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38,043.68 -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37,961.00 -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92,627.80 -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264,712.00 +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187,759.00 +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77,683.20 +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29,059.80 -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29,284.23 -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26,643.00 -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44,603.00 +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35,294.47 -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41,746.20 -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58,458.86 -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115,895.80 +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56,616.00 +160.2%N/A1 $0.84 9/30/202225,900 shares $26,936.00 -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76,209.00 +38.7%N/A1.7 $1.33 8/31/202241,300 shares $55,755.00 -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77,703.00 -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165,482.00 +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109,480.00 -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117,439.00 -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219,191.00 -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319,490.00 +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306,590.00 -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355,250.00 +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345,054.00 -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501,676.00 -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440,628.00 -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439,632.00 +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395,712.00 -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613,262.00 -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851,264.00 +7.4%N/A0 $2.83 12/31/2021280,000 shares $789,600.00 +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797,093.00 +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811,954.00 -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40 7/30/2021119,300 shares $613,202.00 -33.3%0.6%0 $5.14Trump to solve American wealth loss? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 7/15/2021178,800 shares $935,124.00 -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259,235.00 -9.4%0.4%0 $3.73 5/28/202176,700 shares $247,741.00 -15.1%0.5%0 $3.23 5/14/202190,300 shares $263,676.00 -57.1%N/A0 $2.92 4/30/2021210,400 shares $715,360.00 +115.6%N/A0 $3.40 4/15/202197,600 shares $321,104.00 +21.1%N/A0 $3.29 3/31/202180,600 shares $265,980.00 -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239,835.00 -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284,830.00 +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185,009.00 -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180,916.00 +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44,990.00 -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52,965.00 +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33,496.00 -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56,116.50 +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41,580.00 +7.4%0.4%0.3 $1.10 10/15/202035,200 shares $40,128.00 -49.9%0.3%0.2 $1.14 9/30/202070,300 shares $87,172.00 +174.6%0.7%0.1 $1.24 9/15/202025,600 shares $28,416.00 -42.3%0.2%0 $1.11 8/31/202044,400 shares $56,832.00 -28.2%0.4%0.1 $1.28 8/14/202061,800 shares $88,992.00 +8.8%0.6%0.1 $1.44 7/31/202056,800 shares $95,992.00 +11.6%0.5%0.1 $1.69 7/15/202050,900 shares $91,111.00 +110.3%0.5%0.1 $1.79 6/30/202024,200 shares $45,254.00 +505.0%0.2%0.3 $1.87 6/15/20204,000 shares $7,440.00 +263.6%0.0%0.1 $1.86 5/29/20201,100 shares $2,200.00 -8.3%0.0%0 $2.00 5/15/20201,200 shares $2,664.00 -70.7%0.0%0 $2.22 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 73,100 shares of ENTX short. 0.23% of Entera Bio's shares are currently sold short. Learn More on Entera Bio's current short interest. What is a good short interest ratio for Entera Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENTX shares currently have a short interest ratio of 1.0. Learn More on Entera Bio's short interest ratio. Which institutional investors are shorting Entera Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Entera Bio: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Entera Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.23% of Entera Bio's floating shares are currently sold short. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a decline in short interest in April. As of April 15th, there was short interest totaling 73,100 shares, a decline of 2.3% from the previous total of 74,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? 0.23% of Entera Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Entera Bio: PureTech Health plc (0.05%), Erasca, Inc. (14.36%), Sana Biotechnology, Inc. (32.45%), Zevra Therapeutics, Inc. (10.94%), Altimmune, Inc. (32.90%), SNDL Inc. (1.40%), Kamada Ltd. (0.07%), Revance Therapeutics, Inc. (4.32%), Tectonic Therapeutic (14.30%), Taysha Gene Therapies, Inc. (11.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies PureTech Health Short Interest Data Erasca Short Interest Data Sana Biotechnology Short Interest Data Zevra Therapeutics Short Interest Data Altimmune Short Interest Data SNDL Short Interest Data Kamada Short Interest Data Revance Therapeutics Short Interest Data Tectonic Therapeutic Short Interest Data Taysha Gene Therapies Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
